NCT00321256View on ClinicalTrials.gov

Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

July 31, 2007

Conditions
Type 1 Diabetes Mellitus
Interventions
PROCEDURE

human pancreatic islet transplantation

Trial Locations (6)

1211

University Hospital, Department of Surgery, Geneva

25000

University Hospital, Department of Endocrinology, Besançon

34000

University Hospital, Department of Endocrinology, Montpellier

38043

University Hospital, Department of Endocrinology, Grenoble

66000

University Hospital, Department of Endocrinology, Strasbourg

69000

University Hospital, Department of Endocrinology, Lyon

Sponsors

Collaborators (1)

Alfediam
All Listed Sponsors
collaborator

Alfediam

OTHER

lead

University Hospital, Grenoble

OTHER

NCT00321256 - Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study. | Biotech Hunter | Biotech Hunter